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In the traditional medicinal system of Sikkim Clematis buchananiana and Tupistra nutans is used extensively to treat various 
ailments, however, they have not been validated for their anti-inflammatory property by in vitro method. Therefore, the present 
study was carried out to investigate specific ethnomedicinal uses, in-vitro anti-inflammatory property, and phytochemical 
constituents of Clematis buchananiana and Tupistra nutans. The ethnomedicinal usage was studied by calculating the value for 
fidelity level, use-value, and informant consensus factor. Stabilization of human red blood cell membrane and protein denaturation 
method was used to study anti-inflammatory property. The phytochemicals were analysed by the methods described elsewhere. 
Clematis buchananiana was found to be used more frequently for sinusitis, headache, cold and Tupistra nutans for high blood 
pressure, diabetes and stomach-ache. Both C. buchananiana and T. nutans was found to inhibit the HRBC membrane and protein 
denaturation effectively in a dose-dependent manner. However, inhibition of haemolysis and protein denaturation by  
C. buchananiana was found to be higher than T. nutans at all doses. The phytochemical screening revealed the presence of 
anti-inflammatory metabolites such as flavonoids and phenolics in both the plants. The results provide evidence for the 
anti-inflammatory property of C. buchananiana and T. nutans.
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Inflammation is a common protective immunological 
reaction in response to tissue injury which is characterised 
by the accumulation of polymorphonuclear leukocytes 
and macrophages at the sites of tissue injury
1
. These 
cells contain large numbers of lysosomal granules in 
their cytoplasm which on release during inflammatory 
reactions can destroy pathogens as well as the normal 
cells and tissues leading to pathological condition
2
. 
Thus, stabilization of lysosomal membrane holds 
an important prospect to inhibit an inflammatory 
response
3
. Furthermore, denaturation of protein has 
been well documented in inflammation and arthritic 
diseases which results in the production of auto-
antigens
4,5
. Although nonsteroidal anti-inflammatory 
drugs (NSAIDs) are often used to treat inflammation 
they come with various side effects
6,7
.  
In traditional medicine practices of Sikkim, about 
420 plants are used to treat various ailments
8
. In 
the previous studies, elaborative documentation of 
medicinal use of plants from Sikkim has been made, 
out of which some are reported to be used to treat 
inflammatory diseases
9
. Moreover, only a handful of 
plants from Sikkim have been investigated for 
documentation of its anti-inflammatory property 
by experimental evidence-based method
10-13
. Among 
many of the plants used to treat various inflammation-
related diseases, Clematis buchananiana belonging to 
the family Ranunculaceae and Tupistra nutans of the 
family Asparagaceae is being used in the traditional 
medicinal system of Sikkim. The genus Clematis was 
reported to be used for rheumatoid arthritis, bone 
disorder, chronic skin disease, muscle aches, colds, 
headaches, respiratory ailments etc.
14,15
. In the 














 have been investigated for 
anti-inflammatory property. Moreover, the anti-
inflammatory property of Clematis buchananiana has 
not been performed to date. On the other hand, the 
genus Tupistra has been reported to be used for 
diabetes
22,37
. Moreover, only a few studies have been 
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Despite the use of Clematis buchananiana and 
Tupistra nutans in traditional medicinal practices  
of Sikkim the available literature shows that the 
species C. buchananiana and T. nutans have not been 
explored for its anti-inflammatory property by the  
in-vitro method. Therefore, the present study was 
carried out with the objectives to; (i) document the 
knowledge and ethnomedicinal usage of Clematis 
buchananiana and Tupistra nutans among the 
Sikkimese people, (ii) investigate the in-vitro anti-
inflammatory property of methanolic extracts of 
Clematis buchananiana and Tupistra nutans by 
human red blood cell (HRBC) membrane stabilization 
and inhibition of protein denaturation method, (iii) 
screen the phytochemical constituent of C. buchananiana 
and T. nutans. The study may validate the traditional 
knowledge of the use of the plants as an anti-




Documentation of ethno-medicinal usage  
The documentation of traditional uses of Clematis 
buchananiana and Tupistra nutans was performed  
by administration of a standard questionnaire to  
5 individuals from Namchi, South Sikkim; Ranka, 
East Sikkim; Shribadam, West Sikkim during the 
months of September to December 2018. The regions 
were selected on the basis of the availability of the 
plant Clematis buchananiana and Tupistra nutans. 
From the collected data informant consensus factor 
(Fic) was calculated using the formula by Heinrich et 
al. (1998)
24
. The use-value (UV) of each plant was 
calculated according to the formula by Phillips et al. 
(1994)
25
. Fidelity Level was calculated as per the 
formula provided by Friedmen et al. (1986)
26
. 
Clematis buchananiana (accession number-586) and 
Tupistra nutans (accession number-611) were collected 
from the above-mentioned areas of the Sikkim and 
brought to the laboratory of Department of Zoology, 
Sikkim University and was identified by a taxonomist 
from Department of Botany, Sikkim University. 
 
Materials and methods 
 
Plant extract preparation 
The flowers of T. nutans and root of Clematis 
buchananiana were washed with distilled water to 
remove the dust particles and was initially dried at 
room temperature, avoiding direct sunlight and it  
was followed by drying in an incubator at 37°C. The 
dried plant material was ground into a fine powder. 
The extract of the plants was prepared in Soxhlet 
apparatus by mixing 10 gm plant powder with 400 ml 
methanol. The extract was then evaporated in a rotary 
evaporator at 42ºC followed by complete drying in an 
incubator at 37°C. The obtained plant extract was then 
stored at -20°C refrigerator until use. 
 
Preparation of stock solution  
The stock solutions of methanolic extract of 
Clematis buchananiana and Tupistra nutans was 




Test for in-vitro anti-inflammatory property  
All the assays were performed in triplicate for each 
of the different tests by the same investigator. 
 
HRBC membrane protection test 
About 5 ml fresh blood sample was collected from 
the investigator who was not under any dose of Non-
Steroidal Anti-Inflammatory Drug (NSAID) for at 
least 15 days prior to the experiment. To the collected 
blood sample, an equal volume of Alsever’s solution 
was added and centrifuged at 3000 rpm for 10 
minutes after which supernatant was removed and a 
packed RBC pellet was obtained. It was washed three 
times with normal saline. The dissolved RBC pellets 
were reconstituted as 10% (v/v) suspension with iso-
saline (pH=7.2). The reconstituted RBC was used as 
the stock erythrocyte (HRBC) suspension.  
The standard protocol of Shinde et al. (1999)
28
 with 
minor modifications was applied for heat-induced 
haemolysis test. For the assay methanolic extract of 
both the plants and standard drug (diclofenac) were 
prepared into the concentrations of 1 mg/ml, 2 mg/ml, 
3 mg/ml, 4 mg/ml and 5 mg/ml in distilled water.  
A reaction mixture was prepared to consist of 2 ml of 
Hyposaline (0.25% NaCl), 1ml of PBS (0.15 M, pH 
7.4) and 1 ml plant extract or standard drug, 0.5 ml of 
10% HRBC suspension. The control consisted of 1 ml 
distilled water instead of plant extracts, the other 
constituents were similar. The mixture was then 
incubated in an incubator for 30 min at 37°C and 
centrifuge at 2500 rpm for 5 mins. The supernatant 
was isolated gently and the absorbance was read at 
560 nm in a UV-VIS spectrophotometer (Systronics). 
The HRBC membrane protection was calculated by 
the formula: - 
Percentage of Protection= 100 – [(OD1/OD2) x 100] 
Where, OD1= Optical density of test sample 
OD2= Optical density of the control sample 




Protein denaturation test 
The in-vitro protein denaturation test was 
performed following the protocol of Mizushima  
et al. (1968)
29
 and Sakat et al. (2010)
30
 with slight 
modifications. The reaction mixture of 5 ml consisted 
of 0.2 ml of egg albumin, 2.8 ml of phosphate buffer 
saline (pH: 6.4) and 2 ml of varying concentrations  
of the plant extract or standard drug. For the  
controls, double distilled water was used instead of  
plant extracts. The reaction mixture was incubated  
at 37ºC in an incubator for 15 minutes followed  
by heating at 70ºC in a water bath. After cooling  
the absorbance was measured at 660 nm in UV-VIS 
spectrophotometer (Systronics). The percentage of 
inhibition of protein denaturation was calculated by 
the formula: -  
 
Percentage of inhibition = [1- (Abssample/ Abscontrol)] x 
100 
Where, Abssample = Absorbance of the Sample 
Abscontrol = Absorbance of the Control 
 
Phytochemical Analysis 
The qualitative phytochemical analysis was 
performed with powdered plant material and 
methanolic extract of the plants as per the protocol 
described elsewhere (Parekh and Chanda, 2007)
31
. 
The quantitative tests for flavonoids and phenolic 
phytoconstituents were performed as described by 





The data analysis was performed using IBM SPSS 
23. Shapiro-Wilk test was first applied to examine the 
normality of the data. The variables were expressed as 
mean and Standard Error Mean (S.E.M). One-way 
analysis of variance was used to determine a statistically 
significant difference between plant extracts and 
standard drug in membrane protection and protein 
denaturation. Pair-wise Karl Pearson correlation test was 
performed to analyze the relations between the effects of 
methanolic extracts and diclofenac on membrane 
protection and protein denaturation. The p-value of 




Documentation of ethno-medicinal knowledge and usage 
The results show that Clematis buchananiana and 
Tupistra nutans are used to treat various ailments by 
the people of Sikkim and they have an important 
place in the traditional medicinal system. It was noted 
that for Clematis buchananiana the plant parts used 
by people for the medicinal purpose was the root and 
for Tupistra nutans flowers and fruits. However, 
among the two species, Clematis buchananiana (UV= 
0.4) was found to be used most commonly for the 
medicinal purposes to treat sinusitis, headache, cold, 
etc. (Table 1). On the other hand, Tupistra nutans 
(UV=0.3) was reported to be used for the treatment of 
diabetes, high pressure etc. The fidelity level (FL) of 
Clematis buchananiana was found higher in sinusitis 
(68%), followed by headache/migraine (36%). 
However, for Tupistra nutans fidelity level was high 
for high blood pressure (64%) followed by diabetes 
(60%). Even though the informant consensus (Fic) 
value for most of the ailment mentioned was one (1) 
however, for headache and gastric problems it was 0.9 
and 0.5 respectively (Table 1).  
 
In-vitro anti-inflammatory assay 
 
Hypotonicity induced HRBC membrane stabilization test 
The results of the HRBC membrane stabilization 
test is presented in Table 2. The results show that both 
the methanolic extract of Clematis buchananiana and 
Tupistra nutans has the capacity to inhibit the 
haemolysis of HRBC. However, C. buchananiana 
was found to have a higher percentage of inhibition  
to HRBC haemolysis than T. nutans at all the 
concentrations. Moreover, the inhibition of 
haemolysis was found to be higher for the standard 
drug than the plant extracts at all the concentrations. 
At the highest concentration (5 mg/ml), the inhibition 
of haemolysis induced by diclofenac (standard drug) 
and C. buchananiana exhibited almost similar value. 
One-way ANOVA analysis revealed that there was  
no significant difference in protection between  
C. buchananiana and standard diclofenac drug  
(F= 4.227, df=2, p=0.471). However, the protection 
achieved by T. nutans was significantly lower than the 
standard drug (F= 4.227, df=2, p=0.033). Shapiro-
Wilk test shows the sample data are normally 
distributed (0.805). Karl-Pearson correlation test for 
inhibition of haemolysis between plant species and 
drug in varying concentration was found to be dose-
dependent (Table 3). However, C. buchananiana 
(r=1, p=0.001) showed strong correlation with dose 
than Tupistra nutans (r=0.994, p=0.001).  
 
Protein denaturation test 
Results of the protein denaturation test are 
presented in Table 2. Shapiro-Wilk test revealed that 
the sample data are normally distributed (0.603). The 
methanolic extracts of Clematis buchananiana and 




Tupistra nutans inhibited the denaturation of egg 
albumin effectively. However, the higher percentage 
of inhibition of protein denaturation was observed for 
Clematis buchananiana than Tupistra nutans. However, 
the inhibition of egg albumin denaturation by 
diclofenac drug (89.4%) was higher than the plant 
extracts. One-way ANOVA analysis suggested that 
there was no significant difference between the 
inhibitions of protein denaturation by C. buchananiana 
and diclofenac drug (F= 8.535, df=2, p=0.056). 
However, there was a significantly higher inhibition 
of protein denaturation by standard diclofenac drug 




The results of the phytochemical analysis are 
presented in Table 4. The quantitative phytochemical 
Table 1 — Fidelity level (FL), use-value (UV) and informant consensus factor (Fic) values of Clematis buchananiana and Tupistra 
nutans for various ailments. 
Plants Total 
respondents 
Illness Treated FL (%) Use value 
(UV) 
Illness Treated by  
either 
C. buchananiana  
or T. nutans 














Cold 32  
0.4 
Cold 8 1 1 
Nose block 12 Nose block 3 1 1 
Sinusitis 68 Sinusitis 17 1 1 
Nose bleeding 24 Nose bleeding 6 1 1 
Headache/ migraine 36 Headache/ migraine 10 2 0.9 
Gastric 4 Gastric 3 2 0.5 
Toothache 20 Toothache 5 1 1 
Jaundice 8 Jaundice 2 1 1 







Diabetes 60  
 
0.3 
Diabetes 15 1 1 
Stomachache 16 Stomachache 4 1 1 
High blood pressure 64 High blood pressure 16 1 1 
Food Poison 4 Food Poison 1 1 1 
Pneumonia 4 Pneumonia 1 1 1 
Fever 12 Fever 3 1 1 
Headache 4     
Gastric 8     
 
Table 2 — Effect of methanolic extracts of Clematis buchananiana, Tupistra nutans and diclofenac in the protection of HRBC membrane 
and egg albumin protein denaturation [n=3 in each concentration]. 
Concentrations % of HRBC membrane inhibition % of Inhibition of Protein Denaturation 












1mg/ml 59.2 ± 1.6 53.7±9.7 68.4 ± 2.7 33.1 ± 3.5 18.5 ± 2.7 38.2 ± 5.7 
2mg/ml 64.7 ± 0.2 57.7 ± 10.0 72.4 ± 3.3 40.5 ± 7.5 22.2 ± 0.8 70.5 ± 10.6 
3mg/ml 70.7 ± 1.3 64.0 ± 11.6 77.9 ± 2.1 46.3 ± 8.8 26.3 ± 2.4 75.4 ± 12.0 
4mg/ml 76.4 ± 0.7 67.1 ± 11.9 80.3 ± 3.2 51.1 ± 10.1 38.9 ± 7.8 83.1 ± 10.3 
5mg/ml 82.5 ± 0.3 70.9 ± 9.9 83.2 ± 2.6 59.9 ± 6.8 53.3 ± 13.1 89.4 ± 5.0 
 
Table 3 — Karl Pearson’s correlation coefficient (r) test for dose-dependent pairwise correlation between drug, Clematis 
buchananiana and Tupistra nutans with the protection of HRBC membrane and protein denaturation. 
Treatment HRBC membrane inhibition Inhibition of Protein Denaturation 
 r- value p-value r- value p-value 
C. buchananiana vs Concentration 1.000 0.001 1.000 0.001 
T. nutans vs Concentration 0.994 0.001 1.000 0.001 
Diclofenac vs Concentration 0.989 0.001 1.000 0.001 
 




screening of dried powder and methanolic extracts 
from the roots of C. buchananiana and flower of  
T. nutans showed the presence or absence of certain 
phytoconstituents. The quantitative analysis of total 
flavonoid content (TFC) in the root of Clematis 
buchananiana and flower of Tupistra nutans was 
found to be 63.89 mgRt/g, Fw and 47.87 mgRt/g, Fw 
respectively. Further, the total phenolic content in  
C. buchananiana and T. nutans was found to be 17.17 




Medicinal plants have long been recognized as an 
important source of therapeutically beneficial 
compounds. In the earlier study, Pradhan et al. (2008) 
reported the use of roots of Clematis buchananiana 
for treating sinusitis and headache and the 
inflorescence of Tupistra nutans to treat the body 
pain
33
. In the present study, similar medicinal uses of 
Clematis buchananiana and Tupistra nutans as herbal 
medicine have been documented. Further, the use of 
C. buchananiana roots and inflorescence of T. nutans 
was also reported by Idrisi et al. (2010) in their 
study
9
. However, they have not analysed the Fidelity 
level, consensus factor (Fic) and use value (UV) in 
their study. The present study suggested that the use 
of species Clematis buchananiana is higher (UV=0.4) 
than Tupistra nutans (UV=0.3) among the people of 
Sikkim. Furthermore, Clematis buchananiana was 
found to be used more frequently to treat sinusitis 
followed by headache and cold as suggested by high 
FL value. However, unlike the widely available 
literature for use of Tupistra nutans for diabetes, the 
present study observed a higher FL value (64%) for 
high blood pressure than diabetes, showing its 
maximum use to treat high blood pressure which can 
be considered as a new finding.  
The lysosomal enzymes released during inflammation 
cause a variety of disorders that are related to acute or 
chronic inflammation. Thus, stabilization of 
lysosomal membrane is an important step to stop 
inflammatory response by inhibiting the release of 
lysosomal constituents (bactericidal enzymes and 
proteases) of activated neutrophil which promotes 
tissue inflammation and damage upon extracellular 
release
8
. As the membrane of HRBC resembles the 
membrane of lysosome the HRBC membrane 
stabilization method was used in the present 
investigation to evaluate the anti-inflammatory 
property of C. buchananiana and T. nutans. Further, 
the denaturation of protein is well documented in 
inflammation and the protection of denaturation of 
proteins by NSAIDs was reported by Mizushima 
(1964)
34
. As such, the inhibition of protein 
denaturation by the plant extract was evaluated by 
various researchers to investigate the anti-
inflammatory activity
5,35
. Therefore, in the present 
study, HRBC membrane stabilization and inhibition 
of albumin protein denaturation method were 
followed to evaluate the anti-inflammatory property 
of C. buchananiana and T. nutans.  
The results of the present study provide evidence 
for the anti-inflammatory property of Clematis 
buchananiana and Tupistra nutans. However, C. 
buchananiana was found to have a higher potential to 
stabilize the HRBC membrane (Fig. 1) which 
suggests a higher potency of C. buchananiana as an 
anti-inflammatory agent. Moreover, C. buchananiana 
and T nutans could effectively inhibit the protein 
denaturation induced by heat which suggests that it 
can prevent the loss of biological function of 
Table 4 — Phytochemical screening and quantitative test of flavonoid and phenolic content from the roots of Clematis buchananiana  
and flowers of Tupistra nutans. 
Phytochemicals  Results 
C. buchananiana T. nutans 
Flavonoids + + 
Tannins + + 
Phenolics + + 
Terpenoids + + 
Steroids - + 
Glycosides - + 
Anthraquinones - + 
Coumarines + + 
Anthocyanins + + 
Total Flavonoid Content (mgRt/100g, FW) 63.89 47.87 
Total Phenolic Content mgGAE/100g, FW) 17.17 18.59 
*The sign ‘−’ means absent and ‘+’ means present 
 






 (Fig. 2). Various other species from the 
genus Clematis have been reported to possess anti-
inflammatory properties
17,18,21,36
. However, previous 
studies were performed by in-vivo methods such as 
tail immersion test and carrageenan-induced paw 
oedema model in mice
36
, whereas in the present 
investigation C. buchananiana was studied for  
the anti-inflammatory property by in-vitro HRBC 
membrane stabilization and protein denaturation 
method. In the previous studies, it was reported that 
Clematis chinensis has the potential to inhibit the 
inflammation by inhibiting the expression of nuclear 
factor kappa B (NF-κB) p65 subunits, TNF-α and 
COX-2
17
. According to pharmacophylogeny, the 
plants with close genetic relatedness can have similar 
chemical components
15
. As C. chinensis and  
C. buchananiana belong to the same genus, it can be 
supposed that the anti-inflammatory effect of  
C. buchananiana may exhibit a similar mechanism of 
inhibitory effect as C. chinensis. Studies have 
revealed that the non-polar hexane fraction of 
Clematis flammua can inhibit the cytokine 
biosynthesis
21
. Furthermore, the anti-inflammatory 
property of the aerial parts of Clematis vitalba was 
found to be due to the presence of 4-O-coumaroyl-
isovitexine (Vitalboside)
20
. Thus, the presence of 
certain specific compound is well known for having 
anti-inflammatory activity in Clematis sp. Even 
though the presence of these specific molecules was 
not investigated in the present study the anti-
inflammatory activity of C. buchananiana can be 
speculated to be due to the presence of such specific 
compounds which can inhibit the pro-inflammatory 
cytokines.  
The available literature shows that the study of the 
anti-inflammatory effect of Tupistra by HRBC 
membrane stabilization method is very less. In the 
present investigation even though Tupistra nutans 
was found to have an anti-inflammatory effect but it 
was lesser than C. buchananiana which may be due to 
its lesser amount of total flavonoid content. Moreover, 
the family Asparagaceae to which Tupistra belongs 
has species having an anti-inflammatory property
15
. In 
addition to its anti-inflammatory property Tupistra 





 due to which it is often used as 
an anti-diabetic agent and it is also evident from the 
higher FL value in the present study (Table 1). 
Studies have reported the presence of compound-21 in 
the rhizome of Tupistra chinensis which was found  
to inhibit NO production during inflammation
39
.  
The study of Agave sisalana belonging to the family 
Asparagaceae revealed the presence of the steroidal 
molecules hecogenin and tigogenin which was  
found to inhibit inflammation by reducing the levels 
of histamine, serotonin and other inflammatory 
mediators and maintain the prostaglandin E2 (PGE2) 
and leukocyte filtration
40
. In the present investigation, 
T. nutans was found to contain steroids and flavonoids 
(Table 4) which are known as anti-inflammatory 
phytochemicals.  
The preliminary phytochemical screening of the 
plant extracts revealed the presence of flavonoids, 
triterpenes, tannins, phenolics, coumarins in methanolic 
 
 
Fig. 1 — Graphical representation of the percentage of HRBC 
membrane protection by methanolic extracts of Clematis 





Fig. 2 — Graphical representation of inhibition of protein 
denaturation by methanolic plant extracts of Clematis buchananiana, 
Tupistra nutans and diclofenac at different concentrations. 
 




extracts of both C. buchananiana and T. nutans. 
Moreover, the presence of steroids, anthraquinones, 
glycosides were confirmed in T. nutans. The results 
were in accordance with the previous study in  
T. nutans
41
. However, the phytochemical screening of 
C. buchananiana revealed the presence of phenolic 
acids which was not reported in the previous study by 
Subba et al. (2018)
42
. The presence or absence of 
phytochemicals may differ due to the differences in 
geographical location, age difference in individual 
plants, differences in topographical factors and the 
nutrient concentrations of the soil which may be the 
reason behind variation in phytoconstituents and their 
concentration
43
. This might be the reason for non-
agreement of the present study with that of Subba  
et al. (2018), as the species studied by Subba et al. 
(2018) was from Nepal and in the present study,  
C. buchananiana was collected from Sikkim, India
42
. 
Moreover, the presence of phenolic acids and other 
phytochemical compounds from the genus Clematis  
is in agreement with the previous investigation
44,15
. 
The flavonoids and phenolic acids are the 
phytoconstituents of the polyphenolic family which 
act against inflammation
45
 by inhibiting the production 
of pro-inflammatory molecules such as TNF-α, 
leukocyte adhesion factor and nitric oxide (NO) 
produced during inflammation
46
. The anti-inflammatory 
activity also depends upon the levels of total 
flavonoids and phenolic significantly
46
. In the present 
study, the maximum total flavonoid content was 
found in C. buchananiana, whereas the maximum 
total phenolic content was found in Tupistra nutans. 
Thus, the higher level of anti-inflammatory activity 
shown by C. buchananiana can be correlated with a 
higher level of total flavonoid content. Moreover, the 
anti-inflammatory activity of C. buchananiana and  
T. nutans are probably due to the presence of 
flavonoids, coumarins, phenolics, and terpenoids as 
these phytochemicals are found to possess effective 
anti-inflammatory and antioxidant properties.  
In addition, the anti-inflammatory activities of  
C. buchananiana and T. nutans are probably due to 
the inhibitory effects by phytochemicals on enzymes 
involved in the production of chemical mediators of 
inflammation and metabolism of arachidonic acid
47
.  
The present study was undertaken in-vitro 
condition and in-vivo model was not used to assess 
the anti-inflammatory activity of the plant extracts. 
Moreover, only a few qualitative phytochemical 
screenings were performed from the plant extract and 
the phytochemical screening for saponins was not 
performed that was known to be responsible for anti-
inflammatory effect in some species of genus 
Clematis and Tupistra
39,48
. The study of specific 
compounds and their effects that are responsible for 
the anti-inflammatory activity by C. buchananiana 
and T. nutans was not performed in the present study. 
Considering these limitations present study provides 
the evidence for the anti-inflammatory property 
possessed by C. buchananiana and T. nutans.  
 
Conclusions 
The results of the present study provide an 
evidence-based boost for traditional knowledge of the 
usage of C. buchananiana and T. nutans in 
inflammation related diseases, for which it is used 
widely by the people of Sikkim. Future studies are 
warranted with more sophisticated techniques to 
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